Collectively, the US and China accounted for more than 60% of the total investment volume during the quarter, while few key markets outside the US and China registered an upswing in deal volume, though they failed to completely offset the overall decline.
And the UK, France and Canada were among the few key countries that continued to witness consistent growth in VC investments during the review period.
According to Aurojyoti Bose, financial deals analyst at GlobalData, “With the ongoing US-China trade dispute showing no signs of slowdown, VC investors in these two markets will keep a close watch on the developments.
GlobalData reports that the share of deals across all the value ranges mostly remained unchanged/flat across all the months during Q2 2019, while the quarter witnessed the announcement of few mega deals (investment US$1bn), low value deals (investment US$10m) continued to dominate VC investments with 75.2% share in the overall volume.
In addition, all three months registered the highest number of deals in the range of US$1 million to US$5 million.
GlobalData also reports that a total of 1495 deals (with disclosed deal value) were announced in April 2019, out of which low value deals accounted for 75.5% – and it was the only month to record a US$1 billion+ deal in Q2.
The month also had two deals in the range of US$500 million to US$1000 million and the US topped with a total of 891 VC funding deals, with China a distant second position with 112 deals in April.
GlobalData says some of the notable deals in April included the announcement of Grab’s plan to raise US$2 billion and US$568 million Series D funding raised by UiPath.
And the VC investment deal volume (with disclosed deal value) witnessed a decline of 0.4% in May as compared to the previous month, with the month witnessing the announcement of six deals in the range of US$500 million to US$1000 million – the highest during the quarter.
May also witnessed the announcement of the highest number of deals in the range of US$1 million to US$5 million, and low value deals as a percentage of the total deal volume was also the highest (76.8%) during the month.
The number of VC investments declined by 2.6% in the US and 17% in China in May compared to the previous month.
Some of the notable deals announced in May included US$1 billion raised by JD Health and US$750 million raised by Megvii.
And GlobalData reported that June also saw a decline of 14% in VC deal volume (with disclosed deal value) compared to the previous month, while not witnessing any deals valued at more than US$500 million.
Low value deals as a percentage of the total deal volume stood at 72.9% in June, with the number of VC investments for the month declining by 22% in the US – although China "recovered", with the investment volume remaining flat when compared to April 2019 investment levels.